Status:
UNKNOWN
Cost-effectiveness of Urgent-start Therapies Hemodialysis and Peritoneal Dialysis
Lead Sponsor:
Universidade Estadual Paulista Júlio de Mesquita Filho
Conditions:
Cost-effectiveness Analysis
Chronic Kidney Disease Requiring Chronic Dialysis
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate the cost-effectiveness of unplanned dialysis (peritoneal dialysis and hemodialysis) in chronic kidney disease (CKD) during the first year of therapy in a single center.
Detailed Description
Despite evidence of worse outcomes, initiation of renal replacement therapy by unplanned modalities in chronic kidney disease (CKD) patients is the reality in the practice for both hemodialysis and pe...
Eligibility Criteria
Inclusion
- Ambulatorial Chronic Kidney Disease patients stage 5 (eGFR \< 15 ml/min) or stages 4 with abrupt worsening requiring dialysis treatment immediately followed or not by nephrologists prior to Renal Replacement Therapy indication.
Exclusion
- Transitions between HD and PD
- Patients with functional arteriovenous fistula entering hemodialysis
- Patients with functional PD access implanted ate least 48h before the first use
- Patient or family trained in PD and/or with the right adequacy of the home
Key Trial Info
Start Date :
April 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 12 2021
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT03474367
Start Date
April 1 2017
End Date
December 12 2021
Last Update
October 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Botucatu, São Paulo, Brazil, 18606-260